Elucidation and Analysis of Desmethylsibutramine in Food

식품 중 데스메틸시부트라민의 규명 및 분석

  • Kwon, Chan-Hyeok (National Institute of Food and Drug Safety Evaluation) ;
  • Yoon, Tae-Hyung (National Institute of Food and Drug Safety Evaluation) ;
  • Oh, Jae-Ho (National Institute of Food and Drug Safety Evaluation) ;
  • Lee, Kwang-Ho (National Institute of Food and Drug Safety Evaluation) ;
  • Choi, Dong-Mi (National Institute of Food and Drug Safety Evaluation)
  • Received : 2009.12.30
  • Accepted : 2010.02.17
  • Published : 2010.03.31

Abstract

It has been elucidated desmethylsibutramine in food, that is an analogue of sibutramine used for anti-obesity drug. After separating and purifying in food samples, it was analyzed and identified by the instrument such as HPLC/PDA, HPLC/MS, HPLC/MS/MS and NMR. To analyze sibutamine and desmathylsibutramine in foods, they were analyzed and identified by HPLC/PDA after extracting in dichloromethane, filtering, concentration and diluting in methanol. The overall recoveries were ranged from 87% to 91% and the limit of quantitation was $2.5\;{\mu}g/kg$. As results, sibutramine and desmethylsibutramine was not detected in all the selected 54 food samples.

식품 중 비만치료제 시부트라민의 유사물질인 데스메틸시부트라민을 규명하였다. 데스메틸시부트라민 함유 시료로부터 메탄올을 이용하여 대상성분을 추출하고 핵산으로 세척 등을 통하여 정제한 후 HPLC/PDA, HPLC/MS, HPLC/MSIMS 및 NMR로 확인 및 분석하였다. 또한, 식품 중 시부트라민 및 데스메틸시부라민을 분석하기 위하여 균질화한 시료를 디클로로메탄으로 추출하여 여과, 농축하고 메탄올로 희석하여 HPLC/UV로 분석하였다. 평균 회수 87~91%이었으며, 정량한계는 $2.5\;{\mu}g/kg$이었다. 분석 결과 식품시료 54건에서 시부트라민 및 데스메틸시부트라민이 검출되지는 않았다.

Keywords

References

  1. Haslam, D., Phillip, W. and James, T.: Obesity. The Lancet, 366, 1197-1209 (2005). https://doi.org/10.1016/S0140-6736(05)67483-1
  2. 세계보건기구 홈페이지 (http://www.who.int).
  3. 강재헌: 한국인 비만유전체 관련연구, 대한임상유전체의 학회 창립기념 학술대회집, pp. 71-80 (2004).
  4. Michand, K., Forget, H. and Cohen, H.: Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging. Brain and Cogn., 71, 1-8 (2009). https://doi.org/10.1016/j.bandc.2009.02.013
  5. Reedy, S.: An Evidence-Based Review of Obesity and Bariatric Surgery. J. Nurs. Pract., 5, 22-29 (2009). https://doi.org/10.1016/j.nurpra.2008.07.017
  6. Eckel, R.: Obesity. Mechanisms and clinical management. Lippincott Williams & Wilkins, Philadelphia, PA (2003).
  7. Ando, K. and Fujita, T.: Metabolic syndrome and oxidative stress. Free. Radic. Biol. Med., 47, 213-218 (2009). https://doi.org/10.1016/j.freeradbiomed.2009.04.030
  8. Corbalan, M., Morales, E., Canteras, M., Espallardo, A., Hernandez, T. and Garaulet, M.: Effectiveness of cognitive– behavioral therapy based on the Mediterranean diet for the treatment of obesity. Nutrition, 25, 861-869 (2009). https://doi.org/10.1016/j.nut.2009.02.013
  9. Giel, K., Binkele, M., Becker, S., Stubler, P., Zipfel, S. and Enck, P.: Weight reduction and maintenance in a specialized outpatient health care center. Obes Res., 2, 143-150 (2008).
  10. DeWald, T., Khaodhiar, L., Dohahue, M. and Blackbum, G.: Pharmacological and surgical treatments for obesity. Am. Heart J. 151, 604-624 (2006). https://doi.org/10.1016/j.ahj.2005.03.007
  11. James, W., Astrup, A., Finer, N.: Effect of sibutramine on weight maintenance after weight loss: a randomised trial. The Lancet. 356, 2119-2125 (2000). https://doi.org/10.1016/S0140-6736(00)03491-7
  12. 살 빼는 약 바로 알고 복용하세요, 식품의약품안전청 (2007).
  13. Slovacek, L., Pavlik, K. and Slovackova, B.: The effect of sibutramine therapy on occurrence of depression symptoms among obese patients. Nutr. Metab. Cardiovasc. Dis., 18, e43-e44 (2008). https://doi.org/10.1016/j.numecd.2008.04.002
  14. Esposito, P., Rampino, T., Gregorini, M., Soccio, G. and Canton, D.: Severe Symptomatic Hyponatremia During Sibutramine Therapy: A Case Report, 21. Am. J. Kidney Dis., 52, 137-139 (2008). https://doi.org/10.1053/j.ajkd.2008.02.361
  15. Simone, G. and D'Addeo, G.: Sibutramine: Balancing weight loss benefit and possible cardiovascular risk. Nutr. Metab. Cardiovasc. Dis., 18, 337-341 (2008). https://doi.org/10.1016/j.numecd.2008.03.008
  16. 식품의약품안전청 홈페이지 (http://www.kfda.go.kr).
  17. Jeffery, J., Kerrigan, F., Miller, T., Smith, G. and Tometzi, G.: Synthesis of sibutramine, a novel cyclobutylalkylamine useful in the treatment of obesity, and its major human metabolites. J. Chem. Soc. Perkin Trans. 1, 2583-2590 (1996).
  18. Ding, L., Hao, X., Hung, X., Zhang, S.: Simultaneous determination of sibutramine and its N-desmethyl metabolites in human plasma by liquid chromatography-electrospray ionization- mass spectrometry: Method and clinical applications. Anal. Chim. Acta. 492, 241-248 (2003). https://doi.org/10.1016/S0003-2670(03)00209-5
  19. 식품공전, 식품의약품안전청 (2008).